Study guide
9.1 Informed Consent, Treatment Refusal, & Autonomy in Wound Care
NAWCCB WCC Wound Care Certified Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
About the NAWCCB WCC Exam How to Use This Study Guide
2 Assessment: Skin & Tissue Foundations
1.1 Skin Anatomy, Physiology, and Barrier Function 1.2 Phases of Wound Healing & Cellular Events 1.3 Acute vs. Chronic Wounds & Etiology Classification 1.4 TIME and MEASURE Assessment Frameworks 1.5 Wound Bed Tissue Types & Periwound Assessment 1.6 Pain Assessment: Scales, Wound Pain Types, and Procedural Analgesia 1.7 Psychosocial History, Cognitive Status, and Functional Assessment 1.8 Skin Integrity Across the Lifespan: Neonatal, Pediatric, Adult, and Geriatric
3 Assessment: Diagnostic Tools & Risk Assessment
2.1 Vascular Assessment: ABI, TcPO2, and Arterial/Venous Doppler 2.2 Neuropathy & Monofilament Testing in Diabetic Patients 2.3 Pressure Injury Risk Assessment: Braden Scale Subscales & Scoring 2.4 NPIAP Pressure Injury Staging (Stages 1-4, Unstageable, DTPI) 2.5 Exudate Characterization, Biofilm (NERDS/STONEES), & Wound Culture 2.6 Laboratory Interpretation in Wound Care: Albumin, Prealbumin, ESR, A1C, CBC, and CMP 2.7 Risk Assessment Instruments Beyond Braden: Norton, Braden Q, Braden QD, Wagner, and University of Texas
4 Treatment: Dressing Selection & Debridement Modalities
3.1 Principles of Dressing Selection by Exudate & Moisture Balance 3.2 High-Absorbency Dressings: Alginates, Hydrofibers, and Foams 3.3 Barrier & Hydrating Dressings: Hydrocolloids, Transparent Films, and Hydrogels 3.4 Antimicrobial & Biofilm Dressings: Silver, Cadexomer Iodine, and Honey 3.5 Debridement Modalities: Sharp, Enzymatic, Autolytic, Mechanical, & Biosurgical
5 Treatment: Advanced Therapies & Specialized Management
4.1 Negative Pressure Wound Therapy (NPWT) Indications, Settings, & Precautions 4.2 Compression Therapy Protocols & ABI Safety Cutoffs 4.3 DFU Off-loading Hierarchy: TCC, RCW, and Therapeutic Footwear 4.4 Support Surfaces, Microclimate Control, & Repositioning Protocols 4.5 Advanced Biologics, Cellular/Tissue Products (CTPs), & HBOT
6 Reevaluation & Wound Healing Trajectory
5.1 Healing Trajectory Benchmarks & Percent Area Reduction (PAR) 5.2 Serial Wound Measurement, Depth Profiling, & Digital Photography 5.3 Treatment Plan Reassessment & Non-Healing Wound Escalation Triggers 5.4 Biofilm Progression & Systemic Infection Re-evaluation 5.5 Palliative Wound Management: Odor, Exudate, and Pain Control 5.6 Validated Healing Instruments: The PUSH Tool, BWAT, and Evaluating Adherence
7 Risk Reduction & Prevention Strategies
6.1 Pressure Injury Prevention: Bundles, Turning Schedules, & Heel Floating 6.2 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis (IAD) 6.3 Infection Control, Contact Precautions, & Environmental Hygiene 6.4 Prevention of Skin Tears & Medical Adhesive-Related Skin Injuries (MARSI) 6.5 Diabetic & Venous Ulcer Recurrence Prevention Protocols 6.6 At-Risk Populations: Spinal Cord Injury, Stroke, Critical Care, and Cognitive Impairment
8 Patient & Caregiver Education
7.1 Patient & Caregiver Wound Care Teaching & Self-Management 7.2 Diabetic Foot Self-Inspection & Footwear Education 7.3 Nutritional Assessment & Dietary Interventions for Wound Healing 7.4 Off-loading Compliance & Patient Mobility Education 7.5 Recognizing Complications, Infection Signs, & When to Seek Care 7.6 Educating the Interprofessional Team & Developing Educational Media
9 Administration & Program Management
8.1 Wound Care Documentation Standards & Clinical Records 8.2 Admission Wound Screening & Present on Admission (POA) Documentation 8.3 Interdisciplinary Team Roles & Clinical Care Coordination 8.4 Quality Improvement Metrics & HAPI Tracking Programs 8.5 Wound Care Formulary Management & Resource Utilization
10 Legal, Ethical, & Scope of Practice
9.1 Informed Consent, Treatment Refusal, & Autonomy in Wound Care 9.2 HIPAA Compliance & Clinical Photography Privacy Standards 9.3 Scope of Practice Across WCC-Eligible Professions (RN, LPN, PT, OT, DPM, MD/DO, PA) 9.4 HAPI Malpractice Liability & Documentation Defense 9.5 Ethical Considerations in Non-Healing Wounds & End-of-Life Skin Care 9.6 Regulatory Compliance, Coding Standards, & Audit Protection
9.1 Informed Consent, Treatment Refusal, & Autonomy in Wound Care
Key Takeaways Explain This Topic AI
Valid informed consent requires five mandatory legal components: procedure explanation, expected benefits, material risks, treatment alternatives, and practitioner credentials.
Express written or verbal consent is legally required prior to performing invasive procedures such as sharp debridement, punch biopsies, or applying cellular and tissue-based products (CTPs).
Adult patients possessing clinical decision-making capacity maintain the absolute ethical and legal right to refuse any wound care intervention, even when refusal risks sepsis, limb loss, or mortality.
Informed refusal documentation must explicitly detail the capacity assessment, specific risks disclosed, patient rationale, offered alternative therapies, attending notification, and witness sign-off.
Clinical decision-making capacity is a functional, situation-specific assessment conducted by clinicians, whereas legal competence is a global status determined exclusively by a court of law.
Last updated: August 2026
Informed Consent, Treatment Refusal, & Autonomy in Wound Care
Informed consent and treatment refusal are foundational legal and bioethical constructs governing clinical wound management. Certified Wound Care Specialists (WCC) frequently perform interventions that carry inherent physical risks, including conservative sharp debridement (CSD), chemical or surgical cauterization, application of advanced biologic dressings, and chemical debridement agents. To honor patient autonomy and uphold professional legal standards, clinicians must ensure that consent is obtained systematically rather than treated as a routine bureaucratic formality. Furthermore, when patients exercise their autonomous right to decline recommended wound therapies, clinicians must navigate the complex legal requirements of informed refusal documentation.
Essential Legal Elements of Valid Informed Consent
For consent to be legally valid and ethically sound, it must be voluntary, informed, and granted by an individual with decision-making capacity. In wound care practice, five mandatory legal components must be communicated and understood prior to initiating invasive interventions:
Nature and Purpose of the Procedure: A clear, jargon-free explanation of the intervention (e.g., "Using a sterile scalpel and curette to trim away dead, infected tissue from the ulcer bed to promote fresh tissue growth" ).
Expected Benefits: The specific therapeutic goals anticipated from the treatment (e.g., reduction of bacterial bioburden, acceleration of autolytic healing, control of malodor).
Material Risks and Potential Complications: Full disclosure of common and severe risks associated with the procedure, including bleeding, local tissue trauma, pain, transient bacteremia, damage to underlying structures (tendons, nerves, blood vessels), and potential need for secondary surgical intervention.
Reasonable Treatment Alternatives: Explanation of alternative therapeutic options, including non-invasive or conservative modalities (e.g., enzymatic debridement gels, autolytic dressings, mechanical hydro-surgery) and the specific risks and benefits of each alternative.
Risks of Refusing Treatment / Non-Treatment: Explicit discussion of the natural trajectory of the wound if no intervention is performed, including risk of progressive necrosis, cellulitis, osteomyelitis, systemic sepsis, limb amputation, or death.
Practitioner Identity and Credentials: Clear disclosure of the licensure, role, and qualifications of the clinician performing the procedure (e.g., Registered Nurse Certified in Wound Care, Physical Therapist, Nurse Practitioner).
Express vs. Implied Consent in Clinical Practice
Implied Consent: Inferred through a patient's voluntary actions during routine, low-risk, non-invasive procedures (e.g., a patient extending their lower leg and allowing the clinician to remove a secondary bandage or cleanse an intact skin margin).
Express Consent: Explicit verbal or written authorization mandated for invasive or higher-risk wound interventions. Written express consent—documented on a formal institutional consent form signed by the patient or legal surrogate—is standard of care prior to sharp debridement, sharp biopsy, application of cellular and tissue-based products (CTPs), or initiation of negative pressure wound therapy (NPWT) in complex anatomical locations.
Assessment of Clinical Decision-Making Capacity vs. Legal Competence
A critical duty of the wound care clinician is differentiating between clinical decision-making capacity and legal competence when obtaining consent or managing treatment refusal.
Attribute Clinical Decision-Making Capacity Legal Competence
Definition A functional determination of a patient's ability to make a specific healthcare decision at a specific point in time. A global legal status regarding an individual's general capability to manage personal, financial, and legal affairs.
Evaluator Licensed clinical provider (MD, DO, NP, PA, RN, or psychologist) assessing the patient at the bedside. Presiding judge in a probate or family court of law.
Scope Decision-specific and situational (a patient may have capacity to consent to a simple dressing change but lack capacity for complex surgical amputation). Global and persistent (person is legally adjudicated as competent or incompetent).
Fluctuating Nature Can change rapidly due to metabolic state, delirium, sepsis, medication toxicity, or cognitive fatigue. Remains constant until formally altered by subsequent judicial decree.
Clinical Capacity Assessment Protocol (The CURVES Framework)
To verify that a patient possesses decision-making capacity to consent to or refuse a wound care intervention, the clinician must assess four functional cognitive criteria:
Communication: Can the patient clearly communicate their choice choices consistently?
Understanding: Does the patient understand the nature of their wound, the proposed treatment, and the associated risks?
Appreciation: Does the patient appreciate how the information applies to their personal health situation (e.g., acknowledging that an unmanaged diabetic foot ulcer could lead to osteomyelitis)?
Reasoning: Can the patient process the logical consequences of various options and articulate a rational explanation for their choice?
If a patient lacks capacity due to acute encephalopathy, advanced dementia, or severe delirium, consent or refusal authority automatically transfers to the designated Durable Power of Attorney for Healthcare (DPOAHC) or legal court-appointed guardian.
Managing and Documenting Informed Refusal (Against Medical Advice / AMA)
Adult patients with verified decision-making capacity possess an absolute legal right to decline any medical or nursing intervention, including life-saving therapies or essential wound treatments (e.g., refusing compression therapy for venous leg ulcers or refusing offloading boots for heel pressure injuries). A refusal of care does not constitute client abandonment by the clinician, provided the refusal is managed and documented meticulously.
Required Components of Informed Refusal Charting
When a patient declines a recommended wound intervention, the medical record must contain a comprehensive, non-judgmental narrative documenting:
Capacity Verification: Explicit notes demonstrating that the patient possessed decision-making capacity during the discussion.
Detailed Disclosure: Specific documentation of the exact risks discussed, including extreme outcomes (e.g., "Explained to patient that refusing sharp debridement of necrotic heel tissue creates a high risk of deep tissue infection, osteomyelitis, systemic sepsis, and leg amputation" ).
Patient Rationale: Direct quotes or objective summary of the patient's stated reasons for refusal (e.g., pain concerns, financial constraints, personal end-of-life philosophy).
Offered Alternative Plan: Documentation of less invasive or alternative harm-reduction care plans offered and accepted (e.g., applying enzymatic gel debridement when sharp debridement is declined).
Attending Provider & Team Notification: Timely communication of the refusal to the primary physician, attending team, and interprofessional wound care panel.
Witness & Patient Signatures: Obtaining signed formal refusal / AMA documentation signed by the patient (or surrogate) and an independent clinical witness.
Clinical Scenario Required Consent Type Key Legal/Documentation Requirement Risk Mitigation Strategy
Routine Bandage Change Implied Consent Document patient cooperation and wound state in EMR note Maintain verbal communication throughout dressing change
Conservative Sharp Debridement (CSD) Express Written/Verbal Consent Specific consent form listing bleeding, pain, and infection risks Verify nurse practice act scope & institutional privilege
Refusal of Compression Wraps Documented Informed Refusal Detailed EMR narrative of capacity assessment & disclosed risks Offer modified lower-pressure wrap or pneumatic pumps
Unconscious Emergency Patient Emergency Implied Consent Document immediate threat to life/limb and inability to locate surrogate Two-physician sign-off where required by hospital policy
Dementia Patient with DPOAHC Legal Surrogate Consent Obtain consent from designated DPOAHC; seek patient assent Keep copy of legal DPOAHC paperwork active in medical record